MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 07-31-2025
OPKO Health Operating Cycle 2011-2026 | OPK
Annual Operating Cycle OPKO Health
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 285 | 298 | 111 | 56.1 | 53.5 | 97.9 | 85.2 | 93 | 103 | 217 | 219 | 254 | 474 | 446 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 474 | 53.5 | 199 |
Quarterly Operating Cycle OPKO Health
| 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112 | 114 | 55.7 | 96 | 105 | 83.9 | 57.1 | 47.8 | - | 31.3 | 31.3 | 65.5 | 58.5 | 61.6 | 60.5 | 50.8 | 52.8 | 61 | 86.7 | 90.8 | 54.8 | 53.7 | 54.3 | 57.1 | 59.2 | 52.6 | 49.8 | 55.4 | 93.8 | 61.4 | 51.6 | 66.1 | 81.4 | 67.4 | 56.3 | 64.9 | 64 | 124 | 668 | 573 | 71.4 | 228 | 198 | 209 | 87.2 | 225 | 202 | 216 | 119 | 435 | 499 | 501 | 198 | 471 | 385 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 668 | 31.3 | 144 |
Operating Cycle of other stocks in the Diagnostics research industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Anixa Biosciences
ANIX
|
275 | $ 3.11 | -2.51 % | $ 101 K |  USA |
|
Centogene N.V.
CNTG
|
170 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Accelerate Diagnostics
AXDX
|
489 | - | -61.36 % | $ 2.46 M | USA |
 |
BioNano Genomics
BNGO
|
329 | $ 1.45 | -3.67 % | $ 1.84 M | USA |
 |
Aspira Women's Health
AWH
|
73.8 | - | -6.19 % | $ 10.5 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
275 | $ 30.5 | -4.72 % | $ 328 M |  China |
 |
Biocept
BIOC
|
134 | - | -13.05 % | $ 7.29 M | USA |
 |
Castle Biosciences
CSTL
|
97.9 | $ 40.78 | 1.92 % | $ 1.13 B | USA |
 |
Co-Diagnostics
CODX
|
405 | - | - | $ 79.8 M | USA |
 |
DexCom
DXCM
|
204 | $ 70.44 | 1.29 % | $ 27.2 B | USA |
 |
Chembio Diagnostics
CEMI
|
164 | - | 0.22 % | $ 16.8 M | USA |
 |
Guardant Health
GH
|
49.1 | $ 113.62 | 1.32 % | $ 13.9 B | USA |
 |
Global Cord Blood Corporation
CO
|
202 | - | - | $ 399 M | China |
 |
Genetic Technologies Limited
GENE
|
11.8 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
185 | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
114 | - | -11.32 % | $ 2.94 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.22 K | - | - | $ 10.7 B | USA |
 |
Illumina
ILMN
|
198 | $ 147.36 | 4.03 % | $ 23.4 B | USA |
 |
CareDx, Inc
CDNA
|
76.4 | $ 20.08 | 0.35 % | $ 1.08 B | USA |
 |
Danaher Corporation
DHR
|
150 | $ 234.95 | -0.44 % | $ 172 B | USA |
 |
DarioHealth Corp.
DRIO
|
251 | $ 12.48 | 0.28 % | $ 354 M |  Israel |
 |
Enzo Biochem
ENZ
|
206 | - | -8.98 % | $ 14.8 K | USA |
 |
Fulgent Genetics
FLGT
|
77.4 | $ 27.65 | -1.53 % | $ 836 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
216 | - | -20.0 % | $ 1.06 M | USA |
 |
Exact Sciences Corporation
EXAS
|
269 | $ 102.21 | -0.22 % | $ 18.9 B | USA |
 |
Lantheus Holdings
LNTH
|
116 | $ 66.02 | 2.75 % | $ 4.57 B | USA |
 |
Medpace Holdings
MEDP
|
51.5 | $ 602.32 | -1.41 % | $ 18.6 B | USA |
 |
IQVIA Holdings
IQV
|
78 | $ 234.18 | -1.47 % | $ 42.5 B | USA |
 |
QIAGEN N.V.
QGEN
|
172 | - | - | $ 10.6 B |  Niderland |
 |
Heska Corporation
HSKA
|
177 | - | - | $ 1.31 B | USA |
 |
Neogen Corporation
NEOG
|
213 | $ 9.28 | 0.27 % | $ 2.01 B | USA |
 |
National Research Corporation
NRC
|
33 | $ 22.06 | -0.72 % | $ 541 M | USA |
 |
Charles River Laboratories International
CRL
|
67.7 | $ 219.04 | -0.3 % | $ 11.3 B | USA |
 |
Pacific Biosciences of California
PACB
|
183 | $ 2.36 | 6.79 % | $ 599 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
56.9 | $ 188.87 | -0.33 % | $ 21 B | USA |
|
Biodesix
BDSX
|
41.7 | $ 8.85 | 12.25 % | $ 1.15 B | USA |
 |
Mettler-Toledo International
MTD
|
63.7 | $ 1 409.56 | -3.5 % | $ 29.9 B |  Schweiz |
 |
Laboratory Corporation of America Holdings
LH
|
72.9 | $ 272.02 | 0.42 % | $ 22.8 B | USA |
 |
ICON Public Limited Company
ICLR
|
68.5 | $ 176.57 | -3.31 % | $ 14.6 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
135 | $ 688.67 | -3.73 % | $ 56.8 B | USA |
 |
Myriad Genetics
MYGN
|
87.1 | $ 5.65 | -4.56 % | $ 512 M | USA |
 |
ENDRA Life Sciences
NDRA
|
412 | $ 4.67 | -2.3 % | $ 2.51 M | USA |
 |
Agilent Technologies
A
|
161 | $ 135.52 | -2.95 % | $ 41.2 B | USA |